Remgro paid over R600m in transaction fees in Mediclinic deal
The group paid a further R196m in the Distell-Heineken tie-up
27 September 2023 - 13:55
Remgro paid investment bankers, transaction advisers and other actors R612m in transaction costs in a deal that saw it and a partner take full control of Mediclinic, delisting it from the JSE and London Stock Exchange (LSE).
The group said such costs were occasioned by the complexity and geographical spread of the transaction...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.